Volume 17, Number 6—June 2011
Coronavirus HKU1 in Children, Brazil, 1995
Highlight and copy the desired format.
|EID||Góes LG, Durigon EL, Campos AA, Hein N, Passos SD, Jerez JA, et al. Coronavirus HKU1 in Children, Brazil, 1995. Emerg Infect Dis. 2011;17(6):1147-1148. https://dx.doi.org/10.3201/eid1706.101381|
|AMA||Góes LG, Durigon EL, Campos AA, et al. Coronavirus HKU1 in Children, Brazil, 1995. Emerging Infectious Diseases. 2011;17(6):1147-1148. doi:10.3201/eid1706.101381.|
|APA||Góes, L. G., Durigon, E. L., Campos, A. A., Hein, N., Passos, S. D., & Jerez, J. A. (2011). Coronavirus HKU1 in Children, Brazil, 1995. Emerging Infectious Diseases, 17(6), 1147-1148. https://dx.doi.org/10.3201/eid1706.101381.|
To the Editor: Coronavirus HKU1 is a newly identified human coronavirus (HCoV) that was reported first in 2005 in Hong Kong Special Administrative Region, People’s Republic of China; later in Australia, Europe, and the United States, and more recently in Brazil, demonstrating a global distribution (1–3). We examined the circulation of HCoV in Brazil and the possible presence of the new HCoV types, with special attention to coronavirus HKU1, in samples collected back to 1995, tested by using universal coronavirus PCR.
The epidemiologic profile of HCoV was retrospectively investigated with samples collected during March–December 1995 in a pediatric ward of University Hospital, São Paulo University, São Paulo, Brazil. The Ethics Committee on Research Involving Human Subjects of the Institute of Biomedical Sciences, University of São Paulo, approved the study. Samples of nasopharyngeal aspirates were collected from 169 hospitalized children, ages 7 days–15 years, of whom 104 had respiratory symptoms, 23 had enteric disease, and 3 had both (4). The mean age of the study population was 19.6 months (median 7 months). Viral nucleic acid was extracted from specimens by using Trizol (Invitrogen, Carlsbad, CA, USA) following the manufacturer’s instructions. Total RNA was then submitted to reverse transcription PCR with a High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA) by using random primers according to the manufacturer’s instructions. The cDNA obtained was screened with primers able to amplify a 220-bp product in the conserved polymerase region of all known HCoVs (5) and other coronaviruses (e.g., bovine coronavirus). We used cDNA obtained from cultured human rectal tumor cell line HRT-18G cells inoculated with bovine coronavirus strain Kakegawa as positive controls for PCR.
In an attempt to improve the sensitivity of HKU1 detection, we analyzed samples with negative results by PCR with a nested PCR specific for coronavirus HKU1. This nested assay was designed on an alignment of our HKU1-positive sample sequence (BRA169) and different HKU1 genotype sequences deposited in GenBank. Primers Fn-HKU1 (forward 5′-CGTGCYATG CCAAATATTTTGCG-3′, HKU1-NC_006577, nt 15433–15454) and Rn-HKU1 (reverse 5′-TAGCAACCGCCACACATAAC-3′, HKU1-NC_006577, nt 15562–15581) produced an amplicon of 149 bp. The nested PCR was run in a 50-µL reaction comprising 10 µL of PCR product, 1.5 units of DNA Polymerase (Biotools, Madrid, Spain), 1 µmol/L of each primer, 200 µmol/L of each dNTP (Applied Biosystems), 2 mmol/L MgCl2, and 1× buffer. PCR mixtures were heated to 95°C for 5 min, followed by 35 cycles of 1 min at 95°C, 30 s at 62°C, and 40 s at 72°C, followed by a final 10 min at 72°C. Clinical samples positive for HKU1 were used as positive controls in the HKU1 nested PCR. All fragments obtained from PCR and nested PCR were analyzed in a 2% (wt/vol) agarose gel by electrophoresis, stained with 0.5 µg/mL of ethidium bromide, and subsequently sequenced to confirm the type of coronavirus. Nucleotide sequencing reactions were performed on both amplicon strands by using an ABI PRISM Big Dye Cycle Sequencing Kit with the ABI PRISM 3100 automatic sequencer (Applied Biosystems).
Six (3.6%) samples tested positive for HCoV-HKU1: 2 samples by PCR and 4 by nested PCR. HCoV types 229E, OC43, and NL63 were not detected in any sample by PCR. Samples positive for HCoV were associated with pertussis, pneumonia, bronchiolitis, and diarrhea (Table).
In a recent review, an analysis of 18 studies indicated that the median (range) incidence of HCoV-HKU1 was 0.9% (0%–4.4%) (2), which is similar to the detection rate in our study. To our knowledge, the only study that has screened for HKU1 in Brazil found that 0.48% of children were positive for HKU1 (3), which is lower than our results.
Although we did not detect other HCoV types, all HCoV types were detected previously in Brazil in samples collected during 2006–2008 (3,6). The absence of detection of 229E, OC43, and NL63 HCoV might have resulted from the seasonality and natural viral year cycle or from the characteristics of the children studied because we included samples from children hospitalized with or without respiratory disease.
BLAST search (www.ncbi.nlm.nih.gov/blast/Blast.cgi) and phylogenetic analysis of amplicons from PCR and nested PCR indicated that samples were positive for HKU1 genotype B (samples BRA169, BRA90, and BRA99) or HKU1 genotype A (samples BRA09, BRA37, and BRA104). The sequences obtained in this study have been deposited in GenBank under accession nos. FJ931534.1 (BRA169), GU904424 (BRA37), GU904427 (BRA104), GU904423 (BRA09), GU904425 (BRA90), and GU904426 (BRA99).
This may be the oldest collection of human samples in which HKU1 has been detected. To our knowledge, the oldest previous sample positive for HCoV-HKU1 was detected in children in Finland during 1996–1998, without an exact date specified (7). Retrospective studies also have been conducted in the United States and Greece that showed the HKU1 virus in different countries in Europe and North America before its discovery (8,9). We have confirmed the circulation of HKU1 coronaviruses in children in Brazil in 1995.
This work was supported by the São Paulo Research Foundation and the Coordination for the Improvement of University Level Personnel.
- Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y, Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol. 2005;79:884–95.
- Woo PC, Lau SK, Yip CC, Huang Y, Yuen K. More and more coronaviruses: human coronavirus HKU1 viruses. Viruses. 2009;1:57–71.
- Albuquerque MC, Pena GP, Varella RB, Gallucci G, Erdman D, Santos N. Novel respiratory virus infections in children, Brazil. Emerg Infect Dis. 2009;15:806–8.
- Hein N. Epidemiological aspects of the respiratory viruses infection in a pediatric ward [dissertation] [in Portuguese]. São Paulo (Brazil): Universidade de São Paulo; 1997.
- Canducci F, Debiaggi M, Sampaolo M, Marinozzi MC, Berre S, Terulla C, Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease. J Med Virol. 2008;80:716–23.
- Bellei N, Carraro E, Perosa A, Watanabe A, Arruda E, Granato C. Acute respiratory infection and influenza-like illness viral etiologies in Brazilian adults. J Med Virol. 2008;80:1824–7.
- Ruohola A, Waris M, Allander T, Ziegler T, Heikkinen T, Ruuskanen O. Viral etiology of common cold in children, Finland. Emerg Infect Dis. 2009;15:344–6.
- Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Coronavirus HKU1 infection in the United States. Emerg Infect Dis. 2006;12:775–9.
- Papa A, Papadimitriou E, Luna LK, Al Masri M, Souliou E, Eboriadou M, Coronaviruses in children, Greece. Emerg Infect Dis. 2007;13:947–9.
TableCite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
Edison L. Durigon, University of São Paulo, 1374 ICB-II, CEP: 05508-900, São Paulo, São Paulo, Brazil
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: August 03, 2011
- Page last updated: August 03, 2011
- Page last reviewed: August 03, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)